Given that NFAT5 expression is diminished in patients with active IBD (43), approaches aimed at enhancing epithelial NFAT5 activity or its downstream pathways may reinforce gut barrier integrity, improving healing in an inflammatory setting. Here, NFAT5 is linked to inflammatory bowel disease.